Patients should deliberate before interlude Pfizer drug-FDA

<p>(Reuters) – U.S. <span>health regulators</span> pronounced patients should not stop holding <span>Pfizer Inc</span>‘s <span>Zithromax antibiotic</span> but consulting a doctor, after a investigate showed a somewhat aloft rate of genocide among patients holding a drug compared to those on other <span>antibiotics</span>.</p>
<p> The <span>U.S. Food and Drug Administration</span> pronounced it was wakeful of a study, that was published in <span>the New England Journal of Medicine</span>, comparing Zithromax to Bayer’s Cipro and <span>Johnson Johnson</span>‘s Levaquin.</p>
<p> Pfizer’s antibiotic showed a somewhat aloft rate of genocide due to heart complications.</p>
<p> The FDA remarkable that Zithromax belonged to a opposite category of drugs, compared with Cipro and Levaquin.</p>
<p> Pfizer’s sh...